The Analysis of Engineering Technology for Measurement of Atrial Fibrillation

碩士 === 中原大學 === 電機工程研究所 === 101 === The patent is the protection of intellectual property rights, advanced with valuable engineering are protected by patent-pending, this paper is to perform the detection of atrial fibrillation key technology patents inquiries, research and analysis, to fully unders...

Full description

Bibliographic Details
Main Authors: Chih-Ming Liu, 劉志銘
Other Authors: Kang-Ping Lin
Format: Others
Language:zh-TW
Published: 2013
Online Access:http://ndltd.ncl.edu.tw/handle/16200819459185461842
Description
Summary:碩士 === 中原大學 === 電機工程研究所 === 101 === The patent is the protection of intellectual property rights, advanced with valuable engineering are protected by patent-pending, this paper is to perform the detection of atrial fibrillation key technology patents inquiries, research and analysis, to fully understand the technical characteristics and avoidance spaceand breakthrough patented technology threshold, to strengthen patent energy and layout, and enhance competitive advantage. And in-depth understanding of the national status of technology and market barriers to entry. In this study, to atrial fibrillation keyword, patent search 172 atrial fibrillation-related patent research goals, by systematic the patent technical analysis mode, showing atrial fibrillation Patent engineering distribution, engineering analysis classified defibrillation system, power management system, electrode systems, assistive devices for signal analysis systems, algorithms, interface system, the data recording system, the the heart information measured recognition system, communication technology applications and secondary treatment technology for analysis and discussion . Show substantial growth in the underlying trend, atrial fibrillation-related patents in 1992, its key patents are concentrated in a small number of patent holders, such as InControl, Cardiac Pacemakers, and Medtronic and other related companies. Among them, the the InControl company's 17% up to. Detection of atrial fibrillation-related technology is already mature, future technology development should improve the accuracy of the analysis and monitoring in order to reduce the false positive rate is more possibility of development.